DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $204,113 | -31.0% | 9,894 | -1.4% | 0.00% | – |
| Q2 2023 | $296,015 | +12.6% | 10,031 | -12.1% | 0.00% | – |
| Q1 2023 | $262,817 | -4.7% | 11,407 | +15.0% | 0.00% | – |
| Q4 2022 | $275,792 | +25.4% | 9,917 | +101.3% | 0.00% | – |
| Q4 2021 | $220,000 | -29.3% | 4,926 | -20.2% | 0.00% | – |
| Q3 2021 | $311,000 | -37.9% | 6,171 | -3.4% | 0.00% | – |
| Q2 2021 | $501,000 | +17.3% | 6,389 | -14.6% | 0.00% | – |
| Q1 2021 | $427,000 | -32.3% | 7,485 | -0.6% | 0.00% | -100.0% |
| Q4 2020 | $631,000 | – | 7,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
| Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
| Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
| SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
| Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
| Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
| Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
| GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
| Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |